Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3678]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
Novel JAK inhibitor pacritinib proving effective for easing symptoms of...
Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA
Novel JAK inhibitor pacritinib proving effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )
30 May 2015
Novel JAK inhibitor pacritinib proves effective for easing symptoms of...
Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA
Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )
30 May 2015
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance
Dr Jonas Nilsson - Umeå University, Umeå, Sweden
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance ( Dr Jonas Nilsson - Umeå University, Umeå, Sweden )
13 May 2015
Latest in novel approaches to CLL and MCL
Professor Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Latest in novel approaches to CLL and MCL ( Professor Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )
6 May 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015
How is ganetespib regulating the response of tumour cells in lung cancer?
Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
How is ganetespib regulating the response of tumour cells in lung cancer? ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
30 Apr 2015
What are the objectives for CART-meso immunotherapy?
Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA
What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )
30 Apr 2015
How will genomics be applied to patient therapy in future?
Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Apr 2015
Positive results in phase II study of copanlisib treating NHL and CLL
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...
Positive results in phase II study of copanlisib treating NHL and CLL ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
30 Apr 2015
Inside cancer - public lecture
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
29 Apr 2015
Developing treatments for indolent non hodgkin lymphoma
Dr Andrew Davies and Dr Paul Fields
Developing treatments for indolent non hodgkin lymphoma ( Dr Andrew Davies and Dr Paul Fields )
29 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation